Abstract
The aim of the present investigation was to enhance the solubility of exemestane (EXM), by solid dispersion (SD) technique using PEG 6000 as a carrier. Phase solubility studies were conducted with PEG 6000 and PEG 20000 to evaluate the effect of carriers on aqueous solubility of EXM. The aqueous solubility of EXM was favoured with PEG 6000 compared to PEG 20000. SDs of EXM using polyethylene glycol 6000 (PEG 6000) as carrier were prepared in different drug to carrier ratios. Solid-state characterization indicated decrease in crystallinity of the drug. The in vitro dissolution rate of EXM was enhanced from both SDs and tablet formulations prepared using SD compared to pure EXM. The in situ permeability studies investigated using single-pass intestinal perfusion technique in rats revealed increase in effective intestinal permeability (Peff, cm/s) by 4.45 folds with SDs. Thus, EXM-PEG 6000 SDs showed improved solubility and permeability.
Similar content being viewed by others
References
Ahuja N, Katare OP, Singh B (2007) Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water soluble drug using water soluble carriers. Eur J Pharm Biopharm 65:26–38
Ajeet KS, Akash C, Manish S, Satish CU, Rama M, Roop KK (2008) Exemestane loaded self microemulsifying drug delivery system (SMEDDS): development and Optimization. AAPS PharmSciTech 9:628–634
Al-Hamidia H, Edwardsa AA, Mohammad MA, Nokhodchi A (2010) To enhance dissolution rate of poorly water soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations. Colloids Surf B 76:170–178
Bermejo M, Avdeef A, Ruiz A, Nalda R, Ruell JA, Tsinman O, Gonzalez I, Fernandez C, Sanchez G, Garrigues TM, Merino V (2004) PAMPA—a drug absorption in vitro model 7. Comparing rat in situ, Caco-2 and PAMPA permeability of fluoroquinolones. Eur J Pharm Sci 21:429–441
Buzdar AU, Robertson JF, Eiermann W, Nabholtz JM (2002) An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane. Cancer 95:2006–2016
Carr RL (1965) Evaluation flow properties of solids. Chem Eng 72:163–168
Chayapathy I, Piyush G, Arvind KB (2003) Implications of density correction in gravimetric method for water flux determination using rat single-pass intestinal perfusion technique: a technical note. AAPS PharmSciTech 4:1–6
De Waard H, Hinrichs WLJ, Visser MR, Bologna C, Frijlink HW (2008) Unexpected differences in dissolution behavior of tablets prepared from solid dispersions with a surfactant physically mixed or incorporated. Int J Pharm 349:66–73
Goss P, Von Eichel L (2007) Summary of aromatase inhibitor trials: the past and future. J Steroid Biochem Mol Biol 106:40–48
Hanafy A, Langguth P, Spahn-Langguth H (2001) Pretreatment with potent P-glycoprotein ligands may increase intestinal secretion in rats. Eur J Pharm Sci 12:405–415
Higuchi J, Connors K (1965) Phase solubility techniques. Adv Anal Chem Instrum 4:117–212
Jukanti R, Sheela S, Bandari S, Veerareddy PR (2011) Enhanced bioavailability of exemestane via proliposomes based transdermal delivery. J Pharm Sci 100:3208–3222
Kaufmann M, Bajetta E, Dirix LY, Fein LE, Jones SE, Zilembo N, Dugardyn JL, Nasurdi C, Mennel RG, Cervek J, Fowst C, Polli A, Di Salle E, Arkhipov A, Piscitelli G, Miller LL, Massimini G (2000) Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. J Clin Oncol 18:1399–1411
Khan KA (1975) The concept of dissolution efficiency. J Pharm Pharmacol 27:48–49
Kirschner MA (1979) The role of hormones in the development of human breast cancer. In: McGuire WL (ed) Breast cancer 3: advances in research and treatment. Plenum Press, New York, pp 199–226
Mauger JW, Chilko D, Howard S (1986) On the analysis of the dissolution data. Drug Dev Ind Pharm 12:969–992
Maulvi FA, Dalwadi SJ, Thakkar VT, Soni TG, Gohel MC, Gandhi TR (2011) Improvement of dissolution rate of aceclofenac by solid dispersion technique. Powder Technol 207:47–54
Mohammed MM, Adel MM, Magda WS (2010) Insight into tadalafil block copolymer binary solid dispersion: mechanistic investigation of dissolution enhancement. Int J Pharm 402:78–88
Moore JW, Flanner HH (1996) Mathematical comparison of curves with an emphasis on in vitro dissolution profiles. Pharm Technol 20:64–74
Mukne AP, Nagarsenker MS (2004) Triamterene-β-cyclodextrin systems: preparation, characterization and in vivo evaluation. AAPS PharmSciTech 5:19
Nai-Ning S, Quan-Sheng L, Chang-Xiao L (2006) Intestinal permeability of metformin using single-pass intestinal perfusion in rats. World J Gastroenterol 12:4064–4070
Newa M, Bhandari KH, Li DX, Kwon TH, Kim JA, Yoo BK, Woo JS, Lyoo WS, Yong CS, Choi HG (2007) Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm 343:228–237
Paulo C (2001) Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13:123–133
Saharan VA, Kukkar V, Kataria M, Gera M, Choudhury PK (2009) Dissolution enhancement of drugs. Part I: technologies and effect of carriers. Int J Health Res 2:107–124
Serajuddin ATM (1999) Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems and recent breakthroughs. J Pharm Sci 10:1058–1066
Sinko PJ, Hu P, Waclawski AP, Patel NR (1995) Oral absorption of anti-AIDS nucleoside analogues. 1. Intestinal transport of didanosine in rat and rabbit preparations. J Pharm Sci 84:959–965
Staniforth JN (1988) Pharmaceutics. In: Aulton ME (ed) The science dosage form design. Churchill Livingstone, Edinburgh, pp 610–636
Svensson US, Sandstrom R, Carlborg O, Lennernas H, Ashton M (1999) High in situ rat intestinal permeability of artemisinin unaffected by multiple dosing and with no evidence of P-glycoprotein involvement. Drug Metab Dispos 27:227–232
Theobald AJ (2000) Management of advanced breast cancer with endocrine therapy: the role of the primary healthcare team. Int J Clin Pract 54:665–669
Valle M, Salle ED, Jannuzzo MG, Poggesi I, Rocchetti M, Spinelli R, Verotta D (2005) A predictive model for exemestane pharmacokinetics/pharmacodynamics incorporating the effect of food and formulation. Br J Clin Pharmacol 59:355–364
Valleri M, Mura P, Maeshrelli F, Cirri M, Ballerini R (2004) Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev Ind Pharm 30:525–534
Van den Mooter G, Goddeeris C (2008) Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: investigating the relationship between physicochemical characteristics and dissolution behaviour. Eur J Pharm Sci 35:104–113
Varma MVS, Panchagnula R (2005a) Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci 25:445–453
Varma MVS, Panchagnula R (2005b) Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability. J Pharm Sci 94:1694–1704
Yavuz B, Bilensoy E, Sumnu M (2007) Bioavailability file: exemestane. FABAD J Pharm Sci 32:79–89
Yavuz B, Bilensoy E, Vural I, Murat S (2010) Alternative oral exemestane formulation: improved dissolution and permeation. Int J Pharm 398:137–145
Yun-Jie D, Han-Zhou F, Limei Z, Chun-Hui H, Chun-Yan Z (2011) In situ absorption in rat intestinal tract of solid dispersion of Annonaceous acetogenins. Gastroenterol Res Pract 2012:1–9
Zerrouk N, Chemtob C, Arnaud P, Toscani S, Dugue J (2001) In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions. Int J Pharm 225:49–62
Acknowledgments
Authors acknowledge Dr. Reddy’s laboratories, Hyderabad, India for gift sample of EXM. The financial assistance to Basanth Babu Eedara by All India Council of Technical Education (New Delhi, India) in the form of Junior Research Fellowship is duly acknowledged. The authors also thank Mr. T Jayapal Reddy, Chairman, St. Peter’s Institute of Pharmaceutical Sciences for providing the necessary facilities to carry out the work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eedara, B.B., Kankane, M., Jukanti, R. et al. Enhanced solubility and permeability of exemestane solid dispersion powders for improved oral delivery. Journal of Pharmaceutical Investigation 43, 229–242 (2013). https://doi.org/10.1007/s40005-013-0069-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40005-013-0069-0